New Investment Call to Fund Breakthrough Healthtech Ventures
Investment firm Spex Capital and London’s life sciences cluster organisation MedCity have opened their first joint call to identify and fund the next generation of digital health and medtech innovators.
Applications are invited from early-stage health-tech ventures with solutions to problems faced by healthcare systems globally. Interested companies will have six weeks to complete their applications for seed or series A rounds before the call closes at midnight on October 27th, 2021. Spex Capital will look to invest up to a max of £5 million per target company. The average ticket is expected to between £500k and £2 million but smaller tickets will be welcome.